Belgian scientists in Nature with cancer breakthrough

April 16, 2015 News BioVox

Scientists Peter Carmeliet and Sarah-Maria Fendt (KU Leuven/VIB) published in the prestigious Nature journal on their fundamental breakthrough in cancer research. They found a new way to prevent blood vessel formation by blocking the enzyme CPT1a. Tumors obtain nutrients for growth from blood vessels. CPT1a is necessary in endothelial cells to break down fatty acids. This appeared to inhibit the proper formation of DNA and subsequently cell division. In this way blood vessels, necessary for the growth of tumors, can no longer be formed.

Read more about this breakthrough in our Insights Article. Subscribe to our newsletter to stay up to date.

Avatar photo

With a local focus and global reach, the news platform BioVox shares insights into the Benelux life sciences ecosystem with readers across the world. BioVox is an independent publisher, providing its community with quality content and first-row access to interesting breakthroughs and trends in biotech, medtech, agtech, pharma, and more. We shine a spotlight on the latest news and innovations from both our partners and community.

All posts

Subscribe to the BioVox newsletter